Position in HLN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$30,532,823
+$4,542,321 QoQ
Shares Held
3,272,543
+26.0% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 98%
Shared 2%
None 1%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. HLN ranks #10 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,322,319 | $238,741,833 | |
| 2 | VTRS |
Viatris Inc
|
14,288,053 | $226,894,274 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
294,413 | $159,521,790 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
699,125 | $117,830,519 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,411,532 | $83,957,795 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,899,912 | $64,369,013 | |
| 7 | ALKS |
Alkermes plc.
|
1,097,282 | $57,497,573 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
441,831 | $49,016,724 |
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,532,823 | 3,272,543 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $25,990,502 | 2,596,454 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $26,825,051 | 2,653,319 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $23,096,222 | 2,574,830 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $23,368,023 | 2,253,426 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $21,117,021 | 2,052,189 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $19,757,499 | 2,071,017 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $16,875,975 | 1,595,083 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $12,989,195 | 1,572,542 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $11,741,861 | 1,383,023 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $9,094,714 | 1,105,069 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $12,453,354 | 1,495,001 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $7,315,401 | 872,960 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $7,360,479 | 904,236 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $7,994,544 | 999,318 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,859,259 | 962,112 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||